podophyllotoxin has been researched along with Cancer of Gastrointestinal Tract in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, Y; Arimura, Y; Carbone, DP; Imai, K; Koide, H; Matsunaga, Y; Motoya, M; Nosho, K; Sasaki, S; Sasaki, Y; Shinomura, Y; Takagi, H; Tokino, T; Yamamoto, H | 1 |
| Cheng, E; Dukeman, M; Heelan, R; Kelsen, DP; Magill, GB; Sordillo, P; Yagoda, A | 1 |
| Brockner, J; Larsen, V; Storm, O | 1 |
3 other study(ies) available for podophyllotoxin and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
The effect of forced expression of mutated K-RAS gene on gastrointestinal cancer cell lines and the IGF-1R targeting therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Gastrointestinal Neoplasms; Gastrointestinal Tract; Genes, ras; Humans; Mice; Molecular Targeted Therapy; Mutation; Neoplasm Invasiveness; Podophyllotoxin; Proto-Oncogene Proteins p21(ras); Receptor, IGF Type 1; Signal Transduction; Up-Regulation | 2017 |
Phase II trial of etoposide in adenocarcinomas of the upper gastrointestinal tract.
Topics: Adenocarcinoma; Adult; Aged; Drug Evaluation; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Podophyllotoxin | 1983 |
Adjuvant cancer chemotherapy. Development of a dosage schedule for the adjuvant cancer chemotherapy in surgical cases.
Topics: Antineoplastic Agents; Gastrointestinal Neoplasms; Humans; Palliative Care; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Postoperative Care | 1965 |